Microwaving the heart may soon become a routine procedure for the treatment of heart rhythm disorders

Microwaving the heart may soon become a routine procedure for the treatment of heart rhythm disorders, a common cause of heart attack and stroke, reports Marina Murphy in Chemistry & Industry magazine.

The new device will selectively ‘cook’ areas of the human heart at 55°C. The procedure, which takes just a few seconds, produces a lesion that blocks abnormal electrical signals. ‘This is exactly the same as the way a microwave oven heats meat . . . the difference is that the microwave exposure area is controlled much more strictly and localised heating is ensured and monitored,’ said Hank Chiu at the University of Technology, Sydney who are developing the practice.

Destroying (ablating) damaged tissue is a common method of treating rapid irregular heartbeat. Microwaves have been used before, but generally only in combination with other surgical procedures. Chiu hopes new technology will be used routinely as a stand-alone technology. ‘We believe that microwave ablation will become as routine as radio frequency ablation,’ he said.

Radio frequency waves produce shallow lesions, and temperatures can be very high, which can cause blood clots, leading to other complications such as stroke. Microwaves produce deeper lesions and are easier to control and pinpoint for maximum effectiveness. ‘Microwaves could be made available to a wider spectrum of patients instead of only the physically fit who can endure open heart surgery,’ said Chui.

http://www.chemind.org

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Common heart failure drug reduces risk of chemotherapy-induced heart damage in cancer patients